Published: 21 February 2024
Summary
Life science organizations are actively implementing large language models and generative AI technologies according to our November 2023 survey. These survey insights can help CIOs understand industry direction, discern adoption trends and prioritize use cases.
Included in Full Research
Overview
Key Findings
The November 2023 Life Science Research Panel Survey highlights:
A substantial 81% of life science executives believe large language models (LLMs) will have a significant impact on the industry. However, only 60% believe LLMs will have a commensurate impact on their own organizations.
Life science organizations show an increased willingness to pilot generative AI (GenAI) use cases. From July to November 2023, there was a noticeable increase in designating a strategic GenAI lead, policies, development and funding.
Scientific (81%), commercialization (74%) and regulatory (72%) are the top business areas where life science organizations have already implemented or are exploring the implementation
Clients can log in to view the entire
document.